-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
SARS-CoV
CAS No. | Product Name | Inquiry |
---|---|---|
129-46-4 |
Suramin SodiumThe sodium salt of Suramin which is a P2 purinergic antagonist and has been also found to have the effect in blocking the G protein binds to GPCRs so that it was studied the activity against sorts of cancer cell lines. |
|
1311271-71-2 |
SARS-CoV-2-IN-44 |
|
1312711-71-9 |
(25S)-Antcin B |
|
131707-25-0 |
UmifenovirArbidol is an antiviral agent using for the treatment of influenza infection in Russia and China. It inhibits membrane fusion and prevents contact between the virus and target host cells. Fusion between the viral capsid and the cell membrane of the target cell is inhibited and this prevents viral entry to the target cell. Although some Russian studies have shown it to be effective, it is not approved for use in Western countries. |
|
1323633-98-2 |
Fluphenazine-d8 DihydrochlorideFlufenazin-[d8] is the labelled analogue of Flufenazin, which is an antipsychotic medication. |
|
132796-52-2 |
Emodin-[d4]Emodin-[d4] is the labelled analogue of Emodin, which is an anthraquinone found naturally in the roots and barks of numerous plants. It exerts antiproliferative effects in cancer cells that are regulated by different signaling pathways. It has anti-cancer, anti-depressant and anti-microbial effects. |
|
1345406-09-8 |
BPR3P0128 |
|
134863-91-5 |
10-Hydroxyaloin A |
|
1350462-55-3 |
MK-5172 hydrateIn biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical studies with other NS3/4a protease inhibitors. In the replicon assay, MK-5172 demonstrated subnanomolar to low-nanomolar EC50s against genotypes 1a, 1b, and 2a.In rats, MK-5172 showed a plasma clearance of 28 ml/min/kg and plasma half-life of 1.4 hr. When dosed p.o. at 5 mg/kg, the plasma exposure of MK-5172 was good with an AUC of 0.7 uM.hr. The liver exposure of the compound was quite good (23 uM at 4 hr), and MK-5172 remained in liver 24 hr after a single p.o. 5 mg/kg dose. At 24 hr, the liver concentration of MK-5172 was 0.2 uM, which was over 25-fold higher than the IC50 in the replicon assay with 50% NHS. When dosed to dogs, MK-5172 showed low clearance of 5 ml/min/kg and a 3 hr half-life after i.v. 2 mg/kg dosing and had good plasma exposure (AUC=0.4 uM.hr) after a p.o. 1 mg/kg dose. |
|
1352920-57-0 |
Gallinamide A (TFA) |
|
1355050-21-3 |
GS-443902 trisodiumGS-443902 trisodium is a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), with IC50s of 1.1 µM, 5 µM for RSV RdRp and HCV RdRp, respectively. |
|
1356355-11-7 |
Saquinavir-[d9]A deuterated squinavir. Saquinavir binds to the active site of the viral protease and prevents cleavage of viral polyproteins, preventing maturation of the virus. Saquinavir inhibits both HIV-1 and HIV-2 proteases. |
|
1365970-03-1 |
glecaprevirGlecaprevir is a suppressive agent of hepatitis C virus (HCV). Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM. |
|
137433-23-9 |
(R)-Hydroxychloroquine(R)-Hydroxychloroquine is the enantiomer of Hydroxychloroquine which is a medication used for the treatment of certain malaria. Hydroxychloroquine is efficiently inhibits SARS-CoV-2 infection in vitro. |
|
137433-24-0 |
(S)-HydroxychloroquineHydroxychloroquine is a synthetic antimalarial drug, which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling. |
|
1375105-96-6 |
FASN-IN-4FAS-IN-1, a diazaspiro derivative, has been found to be a fatty acid synthase inhibitor that probably have potential biological usage in anticancer study. |
|
1379746-42-5 |
Astodrimer |
|
1398046-21-3 |
ProxalutamideProxalutamide is a non-steroidal androgen receptor (AR) antagonist with potential anti-tumor activity for the treatment of prostate cancer and breast cancer. |
|
1417700-13-0 |
ML188ML188 is a non-covalent SARS-CoV 3CLpro inhibitor with IC50 of 1.5 μM. |
|
1418733-36-4 |
HydroxyethylamineHydroxyethylamine (Compd VII) is a SARS-CoV-2 3CLpro inhibitor with an IC50 of ~10 μM in the spread assay. |
※ Please kindly note that our services are for research use only.